SCM
EW icon

Suvretta Capital Management’s Edwards Lifesciences EW Stock Holding History

Suvretta Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Hold
18,700
– – 0.03% 77
2026
Q1 		$1.5M Buy
18,700
+7,600
+68% +$627K 0.04% 74
2025
Q4 		$946K Hold
11,100
– – 0.02% 83
2025
Q3 		$863K Hold
11,100
– – 0.02% 85
2025
Q2 		$868K Hold
11,100
– – 0.03% 84
2025
Q1 		$805K Hold
11,100
– – 0.03% 92
2024
Q4 		$822K Hold
11,100
– – 0.03% 87
2024
Q3 		$732K Hold
11,100
– – 0.02% 90
2024
Q2 		$1.03M Hold
11,100
– – 0.04% 79
2024
Q1 		$1.06M Buy
+11,100
New +$932K 0.04% 88
2023
Q3 		– Sell
-2,300
Closed -$217K – 95
2023
Q2 		$217K Buy
+2,300
New +$200K 0.01% 96

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Suvretta Capital Management's EW Position: Q2 2026 in Review

Suvretta Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 18,700 shares worth $1.69M. The position accounts for 0.03% of the portfolio, ranked #77.

Suvretta Capital Management first reported a position in EW in Q2 2023 and has held it in 11 quarters since. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Suvretta Capital Management held 18,700 shares of Edwards Lifesciences worth $1.69M as of Q2 2026.
  • Suvretta Capital Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.03% of Suvretta Capital Management's portfolio in Q2 2026, its #77 holding.
  • Suvretta Capital Management first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 11 quarters since.
  • 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.